TY  - BOOK
AU  - Borchiellini,Delphine
TI  - First-line management of advanced or metastatic clear cell renal cancer: How long should immunotherapy and/or anti-angiogenic therapy last? What are the criteria for stopping or continuing treatment?
PY  - 2024///.
							
N1  - 19
UR  - https://shs.cairn.info/journal-innovations-therapeutiques-en-oncologie-2024-HS1-page-9?lang=en&redirect-ssocas=7080
ER  -